Transmittal #
R11692NCD
Issue Date
Subject
National Coverage Determination (NCD) 200.3 - Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease (AD)
Implementation Date
CR #
12950
Publication #
100-03
Provider Education
MLN Matters Article MM12950
Provider Education Release Date